Ingredion (INGR)
Market Price (5/11/2026): $107.36 | Market Cap: $6.8 BilSector: Consumer Staples | Industry: Packaged Foods & Meats
Ingredion (INGR)
Market Price (5/11/2026): $107.36Market Cap: $6.8 BilSector: Consumer StaplesIndustry: Packaged Foods & Meats
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 13%, Dividend Yield is 3.1%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 8.8%, FCF Yield is 6.6% Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 13% Low stock price volatilityVol 12M is 17% Megatrend and thematic driversMegatrends include Health & Wellness Trends, and Vegan & Alternative Foods. Themes include Functional Foods & Beverages, Vegan Products, Show more. | Weak multi-year price returns2Y Excs Rtn is -46%, 3Y Excs Rtn is -75% | Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -2.2%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -4.2%, Rev Chg QQuarterly Revenue Change % is -1.2% Key risksINGR key risks include [1] manufacturing disruptions at capital-intensive facilities, Show more. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 13%, Dividend Yield is 3.1%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 8.8%, FCF Yield is 6.6% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 13% |
| Low stock price volatilityVol 12M is 17% |
| Megatrend and thematic driversMegatrends include Health & Wellness Trends, and Vegan & Alternative Foods. Themes include Functional Foods & Beverages, Vegan Products, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -46%, 3Y Excs Rtn is -75% |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -2.2%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -4.2%, Rev Chg QQuarterly Revenue Change % is -1.2% |
| Key risksINGR key risks include [1] manufacturing disruptions at capital-intensive facilities, Show more. |
Qualitative Assessment
AI Analysis | Feedback
1. Worse-than-Anticipated Q1 2026 Financial Results.
Ingredion reported its first quarter 2026 adjusted diluted earnings per share (EPS) of $2.34 on May 5, 2026, missing the consensus analyst estimate of $2.44 by 4.10%. This figure also represented a significant decrease from the $2.97 adjusted EPS reported in the first quarter of 2025, indicating a notable deterioration in earnings power.
2. Downward Revision of Full-Year 2026 Earnings Guidance.
Following the weaker-than-expected first quarter, Ingredion adjusted its full-year 2026 adjusted EPS guidance downwards to a range of $10.45 to $11.15. This revised outlook is notably lower than the previous guidance of $11.00 to $11.80, which was provided in early February 2026, and falls below the consensus analyst estimate of $11.340.
Show more
Stock Movement Drivers
Fundamental Drivers
The -8.4% change in INGR stock from 1/31/2026 to 5/10/2026 was primarily driven by a -12.0% change in the company's P/E Multiple.| (LTM values as of) | 1312026 | 5102026 | Change |
|---|---|---|---|
| Stock Price ($) | 117.24 | 107.39 | -8.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 7,262 | 7,198 | -0.9% |
| Net Income Margin (%) | 9.1% | 9.4% | 3.2% |
| P/E Multiple | 11.4 | 10.1 | -12.0% |
| Shares Outstanding (Mil) | 64 | 63 | 1.7% |
| Cumulative Contribution | -8.4% |
Market Drivers
1/31/2026 to 5/10/2026| Return | Correlation | |
|---|---|---|
| INGR | -8.4% | |
| Market (SPY) | 3.6% | 13.4% |
| Sector (XLP) | 1.4% | 53.6% |
Fundamental Drivers
The -5.6% change in INGR stock from 10/31/2025 to 5/10/2026 was primarily driven by a -7.2% change in the company's P/E Multiple.| (LTM values as of) | 10312025 | 5102026 | Change |
|---|---|---|---|
| Stock Price ($) | 113.72 | 107.39 | -5.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 7,316 | 7,198 | -1.6% |
| Net Income Margin (%) | 9.2% | 9.4% | 1.3% |
| P/E Multiple | 10.9 | 10.1 | -7.2% |
| Shares Outstanding (Mil) | 64 | 63 | 2.1% |
| Cumulative Contribution | -5.6% |
Market Drivers
10/31/2025 to 5/10/2026| Return | Correlation | |
|---|---|---|
| INGR | -5.6% | |
| Market (SPY) | 5.5% | 15.6% |
| Sector (XLP) | 11.9% | 51.7% |
Fundamental Drivers
The -16.9% change in INGR stock from 4/30/2025 to 5/10/2026 was primarily driven by a -22.7% change in the company's P/E Multiple.| (LTM values as of) | 4302025 | 5102026 | Change |
|---|---|---|---|
| Stock Price ($) | 129.23 | 107.39 | -16.9% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 7,430 | 7,198 | -3.1% |
| Net Income Margin (%) | 8.7% | 9.4% | 7.5% |
| P/E Multiple | 13.0 | 10.1 | -22.7% |
| Shares Outstanding (Mil) | 65 | 63 | 3.2% |
| Cumulative Contribution | -16.9% |
Market Drivers
4/30/2025 to 5/10/2026| Return | Correlation | |
|---|---|---|
| INGR | -16.9% | |
| Market (SPY) | 30.4% | 18.3% |
| Sector (XLP) | 5.7% | 50.2% |
Fundamental Drivers
The 9.6% change in INGR stock from 4/30/2023 to 5/10/2026 was primarily driven by a 51.2% change in the company's Net Income Margin (%).| (LTM values as of) | 4302023 | 5102026 | Change |
|---|---|---|---|
| Stock Price ($) | 97.96 | 107.39 | 9.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 7,946 | 7,198 | -9.4% |
| Net Income Margin (%) | 6.2% | 9.4% | 51.2% |
| P/E Multiple | 13.1 | 10.1 | -22.9% |
| Shares Outstanding (Mil) | 66 | 63 | 3.8% |
| Cumulative Contribution | 9.6% |
Market Drivers
4/30/2023 to 5/10/2026| Return | Correlation | |
|---|---|---|
| INGR | 9.6% | |
| Market (SPY) | 78.7% | 24.6% |
| Sector (XLP) | 18.0% | 47.3% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| INGR Return | 26% | 4% | 14% | 29% | -18% | -1% | 58% |
| Peers Return | 30% | -0% | -14% | -12% | 3% | 27% | 28% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 7% | 95% |
Monthly Win Rates [3] | |||||||
| INGR Win Rate | 67% | 42% | 58% | 50% | 25% | 20% | |
| Peers Win Rate | 60% | 57% | 47% | 38% | 50% | 68% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 60% | |
Max Drawdowns [4] | |||||||
| INGR Max Drawdown | -6% | -17% | -6% | -2% | -21% | -2% | |
| Peers Max Drawdown | -5% | -19% | -27% | -20% | -18% | -6% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -7% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: ADM, BG, IFF, DAR, MKC. See INGR Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 5/8/2026 (YTD)
How Low Can It Go
| Event | INGR | S&P 500 |
|---|---|---|
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -17.6% | -9.5% |
| % Gain to Breakeven | 21.4% | 10.5% |
| Time to Breakeven | 51 days | 24 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -17.5% | -24.5% |
| % Gain to Breakeven | 21.2% | 32.4% |
| Time to Breakeven | 53 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -35.7% | -33.7% |
| % Gain to Breakeven | 55.5% | 50.9% |
| Time to Breakeven | 343 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -14.6% | -19.2% |
| % Gain to Breakeven | 17.1% | 23.7% |
| Time to Breakeven | 871 days | 105 days |
| 2016-2017 Trump Reflation Bond Selloff | ||
| % Loss | -11.6% | -3.7% |
| % Gain to Breakeven | 13.1% | 3.9% |
| Time to Breakeven | 155 days | 6 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -11.6% | -12.2% |
| % Gain to Breakeven | 13.1% | 13.9% |
| Time to Breakeven | 43 days | 62 days |
In The Past
Ingredion's stock fell -2.3% during the 2025 US Tariff Shock. Such a loss loss requires a 2.4% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | INGR | S&P 500 |
|---|---|---|
| 2020 COVID-19 Crash | ||
| % Loss | -35.7% | -33.7% |
| % Gain to Breakeven | 55.5% | 50.9% |
| Time to Breakeven | 343 days | 140 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -35.9% | -17.9% |
| % Gain to Breakeven | 56.0% | 21.8% |
| Time to Breakeven | 388 days | 123 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -51.6% | -53.4% |
| % Gain to Breakeven | 106.6% | 114.4% |
| Time to Breakeven | 415 days | 1085 days |
In The Past
Ingredion's stock fell -2.3% during the 2025 US Tariff Shock. Such a loss loss requires a 2.4% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Ingredion (INGR)
AI Analysis | Feedback
Here are a few analogies to describe Ingredion:
- It's like Intel for the food and beverage industry, providing essential, specialized ingredients rather than computer chips.
- Think of it as 3M, but focused on transforming agricultural products like corn and tapioca into a vast array of ingredients like starches, sweeteners, and proteins for other manufacturers.
AI Analysis | Feedback
```html- Sweeteners: A range of products including glucose syrups, high maltose syrups, high fructose corn syrups, caramel colors, dextrose, polyols, maltodextrins, and glucose syrup solids.
- Starches: Both food-grade and industrial starches derived from corn, tapioca, potato, and rice.
- Biomaterials: Materials produced from starch-based sources for various industrial applications.
- Nutrition Ingredients: Ingredients designed to enhance the nutritional profile of food and beverage products.
- Edible Corn Oil: Refined corn oil used by food packers and producers for cooking and various food products.
- Corn Gluten Feed: A protein-rich byproduct used as feed for chickens, pet food, and aquaculture.
- Fruit and Vegetable Products: Offerings such as concentrates, purees, essences, pulse proteins, and hydrocolloids systems and blends.
AI Analysis | Feedback
nullAI Analysis | Feedback
nullAI Analysis | Feedback
Here is the management team for Ingredion (symbol: INGR):James P. Zallie, President and Chief Executive Officer
James P. Zallie has served as President and Chief Executive Officer of Ingredion Incorporated since January 2018, and was elected to its Board of Directors in September 2017. He joined Ingredion in 2010 when the company acquired National Starch LLC, a specialty starches leader, where he had served as President and CEO. At National Starch, he oversaw strategic investments, restructured assets, and led the business through its acquisition by Ingredion. During his tenure at Ingredion, he has been instrumental in executing the company's growth strategy, overseeing the global specialty portfolio, and leading the integration of several key acquisitions. He also was the architect of Ingredion Idea Labs, a global network of innovation centers.
James D. Gray, Executive Vice President and Chief Financial Officer
James D. Gray is the executive vice president and chief financial officer at Ingredion, responsible for setting the financial direction and overseeing global accounting, finance, internal audit, treasury, investor relations, and tax functions. He joined Ingredion in 2014, following a 12-year tenure with PepsiCo, Inc., where he held executive leadership functions as chief financial officer of the Gatorade division, and vice president of finance for PepsiCo, Inc. and PepsiCo Beverages North America. Prior to PepsiCo, Inc., Gray worked at Bain & Company for ten years, leading strategic growth projects in the U.S. and Europe.
Tanya Jaeger de Foras, Senior Vice President, Chief Legal Officer, Corporate Secretary and Chief Compliance Officer
Tanya Jaeger de Foras was appointed Senior Vice President, Chief Legal Officer, Corporate Secretary and Chief Compliance Officer, effective November 29, 2021. She is responsible for the oversight of Ingredion's global legal, corporate governance, compliance, and government relations functions. Prior to joining Ingredion, Ms. Jaeger de Foras held leadership roles at Whirlpool Corporation and Luxottica S.p.A., and spent 10 years at Pfizer, Inc., in roles of increasing responsibility including assistant general counsel and chief counsel for the company's specialty care European business unit.
Eric Seip, Senior Vice President, Global Operations and Chief Supply Chain Officer
Eric Seip joined Ingredion as Senior Vice President, Global Operations and Chief Supply Chain Officer, effective January 11, 2021. In this role, he leads the company's global manufacturing, supply chain, and procurement functions, and is accountable for transitioning the company to a global operating model. Before joining Ingredion, Seip worked with Ecolab and its spin-off ChampionX as a senior vice president of global supply chain. Prior to Ecolab, he led global operations and supply chain for Isola Group, which was a TPG portfolio company. He brings more than 30 years of global operations and supply chain experience.
Michael Leonard, Senior Vice President, Chief Innovation Officer and Head of Protein Fortification
Dr. Michael Leonard was appointed Senior Vice President, Chief Innovation Officer, and Head of Protein Fortification, effective May 13, 2024. He brings over two decades of experience in product development and commercialization within the food and beverage sector. His career includes leadership positions at MycoTechnology, where he served as CEO, and Motif FoodWorks, where he was both CEO and CTO, focusing on plant-based food ingredient innovation.
AI Analysis | Feedback
Ingredion (INGR) faces several key risks to its business, primarily stemming from its reliance on agricultural commodities, operational complexities, and market demand fluctuations.Key Risks for Ingredion (INGR)
1. Volatility in Raw Material Costs and Supply Chain Reliance: Ingredion's core business relies heavily on agricultural commodities, particularly corn and other starch-based materials. The company is exposed to significant risks from price fluctuations and availability issues of these raw materials. Challenges in passing increased raw material costs to customers can directly impact profitability and financial performance.
2. Operational Disruptions and Production Challenges: As a global ingredient solutions provider with numerous manufacturing facilities, Ingredion is susceptible to operational difficulties and disruptions. Incidents such as the fire at its largest U.S. facility, the Argo Chicago plant in late June 2025, have demonstrated a material negative impact on operating income and production capabilities. Broader supply chain disruptions, including those caused by pandemics or climate change, also pose risks to the company's operations.
3. Market and Demand Headwinds: Ingredion operates in a highly competitive environment and is sensitive to shifts in consumer preferences and macroeconomic conditions. The company has experienced reduced volume demand for its industrial ingredients and sweeteners, particularly in regions like Latin America (due to a brewing industry slump) and the U.S., influenced by factors such as rising retail prices and overall macroeconomic uncertainty. This softening demand impacts sales volumes and the company's ability to maintain or grow its market share.
AI Analysis | Feedback
nullAI Analysis | Feedback
Ingredion (INGR) operates in several addressable markets for its main products and services, with global market sizes detailed below:
- Food Starches: The global food starch market size was valued at USD 23.74 billion in 2025 and is projected to grow to USD 38.68 billion by 2034.
- Industrial Starches: The global industrial starch market size was valued at USD 137.08 billion in 2025, projected to grow to USD 279.55 billion by 2034.
- Sweeteners (overall): The global sweeteners market size stood at USD 109.18 billion in 2024 and is expected to grow steadily from USD 113.17 billion in 2025 to reach nearly USD 156.26 billion by 2034.
- Caramel Colors: The global caramel color market size was worth around USD 1.14 billion in 2024 and is predicted to grow to around USD 1.98 billion by 2035.
- Dextrose: The global dextrose market size was valued at USD 7.62 billion in 2025. The market is projected to grow from USD 8.30 billion in 2026 to USD 16.41 billion by 2034.
- Maltodextrins: The global maltodextrin market size was valued at USD 4.6 billion in 2025 and is projected to reach USD 7.9 billion by 2034.
- Biomaterials: The global biomaterials market size was estimated at USD 236.99 billion in 2025 and is projected to reach USD 836.54 billion by 2033.
- Nutrition Ingredients: The global nutritional ingredients market reached US$ 182.5 billion in 2022 and is expected to reach US$ 325.4 billion by 2031.
- Edible Corn Oil / Refined Corn Oil: null
- Corn Gluten Feed: The global corn gluten feed market size is expected to be valued at US$ 8.2 billion in 2026 and projected to reach US$ 11.4 billion by 2033.
- Pulse Proteins: The global pulse protein market size was valued at USD 20.31 billion in 2024 and is expected to reach USD 35.69 billion by 2032.
- Functional Food Ingredients (for fruit and vegetable products, hydrocolloids systems and blends): The global functional food ingredients market size was estimated at USD 128.12 billion in 2025 and is predicted to increase from USD 135.18 billion in 2026 to approximately USD 210 billion by 2035.
AI Analysis | Feedback
Here are the expected drivers of future revenue growth for Ingredion (INGR) over the next 2-3 years:
- Growth in Texture and Healthful Solutions: Ingredion is strategically focused on its Texture and Healthful Solutions (T&HS) segment, which is characterized by higher average selling prices and gross margins. The company anticipates mid-single-digit to high-single-digit increases in net sales and operating income for this segment in 2025, and expects operating income to be up substantially by high double-digits for the full year 2025, demonstrating market demand for these specialized, nature-plus-technology solutions. This segment is a key driver, with strong Q4 2024 performance showing double-digit sales volume growth.
- Expansion in Plant-Based Proteins: Ingredion has identified plant-based proteins as a high-growth, high-value market opportunity, aligning with consumer demand for sustainable and great-tasting alternatives to animal-based proteins. The company has made significant investments to accelerate the production of plant-based proteins, expanding its portfolio of pulse-based flours, concentrates, and isolates. This strategic focus aims to aggressively capture market share in the rapidly growing plant-based category. The plant-based protein segment is expected to reach cash breakeven towards late 2024, indicating a path to profitability.
- Innovation and New Product Development (especially Clean Label and Sugar Reduction): Innovation is a core engine for Ingredion's profitable growth, particularly in developing differentiated ingredient solutions that address evolving market trends like health and wellness, clean label requirements, and sugar reduction. The global sugar reduction trend is a major tailwind for Ingredion's portfolio, and the company leverages its Idea Labs to co-create solutions with customers, enabling rapid prototyping and higher product success rates, including AI-driven predictive formulation.
- Strategic Geographic Expansion and Strengthening Market Presence: Ingredion is focused on strengthening its presence in key global markets. For instance, the company expects its Latin America (LATAM) operating income to grow by mid-single digits in 2025, building on positive results in regions like Mexico and the Andean countries in 2024. Additionally, Ingredion has made strategic investments in India to expand into high-value pharmaceutical applications, acquiring Amishi Drugs & Chemicals and securing a majority position in Mannitab Pharma Specialities, recognizing India as one of the fastest-growing pharmaceutical markets globally.
- Operational Efficiencies and Cost Savings Programs: While not a direct revenue driver, Ingredion's focus on operational streamlining and cost savings through programs like "Cost2Compete" is expected to contribute to future profitability, which can support further investments in growth areas. The Cost2Compete program, launched in 2024, targets $50 million in run-rate savings by the end of 2025. These efficiencies, coupled with targeted investments, boost profitability and position the company for sustained expansion.
AI Analysis | Feedback
Share Repurchases
- Ingredion's Board of Directors authorized a new stock repurchase program in November 2025 to repurchase up to 8 million shares of its outstanding common stock, effective through December 31, 2028. This program replaced an existing one that had approximately 2.1 million shares remaining.
- In 2025, Ingredion repurchased 1.8 million outstanding common shares at a net cost of $224 million.
- In 2024, the company executed $216 million in share repurchases.
Share Issuance
- No significant information is available regarding large dollar amounts of share issuances over the last 3-5 years. The company's shares outstanding have generally declined, indicating net repurchases.
Inbound Investments
- No information is available regarding large investments made in Ingredion by third-parties, such as a strategic partner or a private equity firm, over the last 3-5 years.
Outbound Investments
- In June 2022, Ingredion acquired Amishi Drugs, a manufacturer of pharmaceutical drugs based in Ahmedabad.
- In April 2021, the company acquired KaTech, a firm specializing in texture and stabilization solutions for food and beverages.
- In November 2020, Ingredion acquired 100% ownership of Verdient Foods Inc. to bolster its plant-based protein offerings, increasing its total investment in plant-based proteins to over $200 million by year-end 2020.
Capital Expenditures
- Net capital expenditures for full-year 2025 were $433 million, representing an increase of $138 million from 2024. This increase was primarily directed towards high-return projects, including leveraging incentives from the Inflation Reduction Act (IRA) for its Indianapolis plant to improve cost efficiency.
- For the full year 2024, capital expenditures amounted to $301 million, following $316 million in 2023.
- Ingredion anticipates capital expenditures for the full year 2026 to be approximately $400 million to $440 million, with a continued focus on strategic investments such as a starch modernization project at the Indianapolis facility and expanding the Belcamp blending center to support growth in customized texture solutions.
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| Ingredion Earnings Notes | 12/28/2026 | |
| How Low Can Ingredion Stock Really Go? | 10/17/2025 | |
| Ingredion vs Verizon Communications: Which Is A Better Investment? | 08/18/2025 | |
| Ingredion vs Cal-Maine Foods: Which Is A Better Investment? | 08/18/2025 | |
| How Does Ingredion Stock Stack Up Against Its Peers? | 08/13/2025 | |
| Better Bet Than INGR Stock: Pay Less Than Ingredion To Get More From PCG, EIX | 08/12/2025 | |
| Better Bet Than INGR Stock: Pay Less Than Ingredion To Get More From CALM, PPC | 08/12/2025 | |
| INGR Dip Buy Analysis | 07/10/2025 | |
| ARTICLES | ||
| Stocks Trading At 52-Week Low | 11/25/2025 |
Trade Ideas
Select ideas related to INGR.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 04102026 | ELF | e.l.f. Beauty | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -1.8% | -1.8% | -6.2% |
| 04022026 | IPAR | Interparfums | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 0.7% | 0.7% | -0.3% |
| 04022026 | COKE | Coca-Cola Consolidated | Quality | Q | Momentum | UpsideQuality Stocks with Momentum and UpsideBuying quality stocks with strong momentum but still having room to run | 5.5% | 5.5% | -5.2% |
| 03272026 | MZTI | Marzetti | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -5.0% | -5.0% | -8.6% |
| 03272026 | TAP | Molson Coors Beverage | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -1.5% | -1.5% | -2.3% |
| 02292020 | INGR | Ingredion | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -2.0% | 11.9% | -27.0% |
| 12312018 | INGR | Ingredion | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -9.5% | 4.7% | -18.7% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 79.35 |
| Mkt Cap | 16.9 |
| Rev LTM | 8,993 |
| Op Inc LTM | 1,044 |
| FCF LTM | 500 |
| FCF 3Y Avg | 714 |
| CFO LTM | 932 |
| CFO 3Y Avg | 1,171 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 1.7% |
| Rev Chg 3Y Avg | -3.4% |
| Rev Chg Q | 6.9% |
| QoQ Delta Rev Chg LTM | 1.6% |
| Op Inc Chg LTM | -6.3% |
| Op Inc Chg 3Y Avg | -0.3% |
| Op Mgn LTM | 7.7% |
| Op Mgn 3Y Avg | 6.9% |
| QoQ Delta Op Mgn LTM | -0.1% |
| CFO/Rev LTM | 10.8% |
| CFO/Rev 3Y Avg | 12.7% |
| FCF/Rev LTM | 6.1% |
| FCF/Rev 3Y Avg | 7.0% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 16.9 |
| P/S | 1.3 |
| P/Op Inc | 19.8 |
| P/EBIT | 17.1 |
| P/E | 29.6 |
| P/CFO | 12.4 |
| Total Yield | 5.1% |
| Dividend Yield | 1.6% |
| FCF Yield 3Y Avg | 5.8% |
| D/E | 0.3 |
| Net D/E | 0.3 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 1.9% |
| 3M Rtn | 8.7% |
| 6M Rtn | 33.0% |
| 12M Rtn | 39.4% |
| 3Y Rtn | 4.4% |
| 1M Excs Rtn | -6.2% |
| 3M Excs Rtn | 2.0% |
| 6M Excs Rtn | 21.4% |
| 12M Excs Rtn | 9.0% |
| 3Y Excs Rtn | -72.2% |
Comparison Analyses
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Food & Industrial Ingredients (F&II) - Latin America (LATAM) | 2,497 | 2,668 | |||
| Texture & Healthful Solutions (T&HS) | 2,417 | 2,566 | |||
| Food & Industrial Ingredients (F&II)- United States(U.S.) /Canada | 2,244 | 2,429 | |||
| All Other | 475 | 743 | |||
| Corporate | 0 | 0 | |||
| Intersegment sales | -203 | -246 | |||
| Single Segment | 7,946 | 6,894 | 5,987 | ||
| Total | 7,430 | 8,160 | 7,946 | 6,894 | 5,987 |
| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Food & Industrial Ingredients (F&II) - Latin America (LATAM) | 483 | 452 | |||
| Food & Industrial Ingredients (F&II)- United States(U.S.) /Canada | 373 | 298 | |||
| Texture & Healthful Solutions (T&HS) | 350 | 394 | |||
| Other matters | -6 | -1 | |||
| Restructuring and resegmentation costs | -18 | -1 | |||
| All Other | -22 | -2 | |||
| Impairment charges | -109 | -10 | |||
| Corporate | -168 | -173 | |||
| Acquisition/integration costs | 0 | ||||
| Total | 883 | 957 |
Price Behavior
| Market Price | $107.39 | |
| Market Cap ($ Bil) | 6.8 | |
| First Trading Date | 12/11/1997 | |
| Distance from 52W High | -21.7% | |
| 50 Days | 200 Days | |
| DMA Price | $111.93 | $115.21 |
| DMA Trend | down | down |
| Distance from DMA | -4.1% | -6.8% |
| 3M | 1YR | |
| Volatility | 16.3% | 16.6% |
| Downside Capture | 0.37 | 0.27 |
| Upside Capture | 10.22 | 11.53 |
| Correlation (SPY) | 15.4% | 20.3% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 0.12 | 0.07 | 0.13 | 0.21 | 0.25 | 0.33 |
| Up Beta | -0.13 | -0.12 | 0.04 | -0.15 | 0.20 | 0.39 |
| Down Beta | 0.51 | -0.47 | 0.11 | 0.30 | 0.37 | 0.23 |
| Up Capture | 16% | 14% | 10% | 25% | 7% | 11% |
| Bmk +ve Days | 15 | 22 | 31 | 66 | 141 | 428 |
| Stock +ve Days | 10 | 19 | 30 | 60 | 124 | 384 |
| Down Capture | 136% | 44% | 25% | 39% | 44% | 61% |
| Bmk -ve Days | 4 | 18 | 30 | 56 | 108 | 321 |
| Stock -ve Days | 11 | 23 | 33 | 63 | 126 | 367 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with INGR | |
|---|---|---|---|---|
| INGR | -18.7% | 16.5% | -1.42 | - |
| Sector ETF (XLP) | 6.2% | 12.6% | 0.20 | 51.9% |
| Equity (SPY) | 29.0% | 12.5% | 1.83 | 21.3% |
| Gold (GLD) | 39.8% | 27.0% | 1.22 | 19.2% |
| Commodities (DBC) | 50.6% | 18.0% | 2.21 | 10.6% |
| Real Estate (VNQ) | 13.0% | 13.5% | 0.66 | 42.8% |
| Bitcoin (BTCUSD) | -17.4% | 42.1% | -0.34 | 10.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with INGR | |
|---|---|---|---|---|
| INGR | 5.5% | 21.2% | 0.19 | - |
| Sector ETF (XLP) | 6.5% | 13.2% | 0.27 | 47.1% |
| Equity (SPY) | 12.8% | 17.1% | 0.59 | 38.1% |
| Gold (GLD) | 20.9% | 17.9% | 0.95 | 10.4% |
| Commodities (DBC) | 13.8% | 19.1% | 0.59 | 11.4% |
| Real Estate (VNQ) | 3.4% | 18.8% | 0.08 | 40.7% |
| Bitcoin (BTCUSD) | 7.0% | 56.0% | 0.34 | 13.2% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with INGR | |
|---|---|---|---|---|
| INGR | 1.9% | 24.9% | 0.09 | - |
| Sector ETF (XLP) | 7.7% | 14.7% | 0.39 | 50.4% |
| Equity (SPY) | 15.1% | 17.9% | 0.72 | 47.6% |
| Gold (GLD) | 13.4% | 15.9% | 0.69 | 6.8% |
| Commodities (DBC) | 9.3% | 17.8% | 0.44 | 20.2% |
| Real Estate (VNQ) | 5.8% | 20.7% | 0.24 | 47.1% |
| Bitcoin (BTCUSD) | 67.8% | 66.9% | 1.07 | 13.3% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 2/3/2026 | 2.6% | 1.7% | -3.1% |
| 11/4/2025 | -5.9% | -5.9% | -5.2% |
| 8/1/2025 | -3.9% | -4.0% | -1.5% |
| 5/6/2025 | 3.6% | 2.7% | 2.7% |
| 2/4/2025 | -5.6% | -5.3% | -4.1% |
| 11/5/2024 | 15.5% | 11.7% | 11.5% |
| 8/6/2024 | 6.6% | 6.9% | 12.2% |
| 5/8/2024 | 1.6% | 1.3% | -0.3% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 13 | 13 | 11 |
| # Negative | 11 | 11 | 13 |
| Median Positive | 4.0% | 4.0% | 10.5% |
| Median Negative | -3.9% | -4.0% | -3.2% |
| Max Positive | 15.5% | 16.1% | 18.7% |
| Max Negative | -13.2% | -10.0% | -11.4% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 03/31/2026 | 05/08/2026 | 10-Q |
| 12/31/2025 | 02/17/2026 | 10-K |
| 09/30/2025 | 11/07/2025 | 10-Q |
| 06/30/2025 | 08/11/2025 | 10-Q |
| 03/31/2025 | 05/09/2025 | 10-Q |
| 12/31/2024 | 02/20/2025 | 10-K |
| 09/30/2024 | 11/08/2024 | 10-Q |
| 06/30/2024 | 08/08/2024 | 10-Q |
| 03/31/2024 | 05/09/2024 | 10-Q |
| 12/31/2023 | 02/21/2024 | 10-K |
| 09/30/2023 | 11/07/2023 | 10-Q |
| 06/30/2023 | 08/08/2023 | 10-Q |
| 03/31/2023 | 05/08/2023 | 10-Q |
| 12/31/2022 | 02/21/2023 | 10-K |
| 09/30/2022 | 11/07/2022 | 10-Q |
| 06/30/2022 | 08/09/2022 | 10-Q |
Recent Forward Guidance [BETA]
Latest: Q4 2025 Earnings Reported 2/3/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 EPS | 11 | 11.4 | 11.8 | 1.7% | Higher New | Guidance: 11.2 for 2025 | |
| 2026 Effective Tax Rate | 25.5% | 26.25% | 27.0% | ||||
| 2026 Free Cash Flow | 820.00 Mil | 880.00 Mil | 940.00 Mil | 3.5% | Higher New | Guidance: 850.00 Mil for 2025 | |
| 2026 Capital Expenditures | 400.00 Mil | 420.00 Mil | 440.00 Mil | 1.8% | Higher New | Guidance: 412.50 Mil for 2025 | |
Prior: Q3 2025 Earnings Reported 11/4/2025
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2025 Reported EPS | 11.1 | 11.2 | 11.3 | -2.5% | Lowered | Guidance: 11.5 for 2025 | |
| 2025 Adjusted EPS | 11.1 | 11.2 | 11.3 | -1.3% | Lowered | Guidance: 11.3 for 2025 | |
| 2025 Cash from Operations | 800.00 Mil | 850.00 Mil | 900.00 Mil | -4.2% | Lowered | Guidance: 887.50 Mil for 2025 | |
| 2025 Capital Expenditures | 400.00 Mil | 412.50 Mil | 425.00 Mil | 0 | Affirmed | Guidance: 412.50 Mil for 2025 | |
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Uribe, Jorge A | Direct | Sell | 4022026 | 112.66 | 1 | 83 | 1,491,264 | Form | |
| 2 | Gable, Davida Marie | VP Corp. Controller, Finance | Direct | Sell | 3192026 | 112.44 | 375 | 42,163 | 799,429 | Form |
| 3 | Zallie, James P | President and CEO | Direct | Sell | 2192026 | 116.55 | 9,958 | 1,160,605 | 3,847,383 | Form |
| 4 | Fernandes, Larry | SVP, Chief Comm & Sust Officer | Direct | Sell | 2192026 | 116.55 | 1,125 | 131,119 | 3,556,420 | Form |
| 5 | Zallie, James P | President and CEO | Direct | Sell | 2122026 | 119.66 | 33,597 | 4,020,217 | 6,002,933 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.